Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves’ Orbitopathy
Authors:
- Erika GalgocziEGErika Galgoczi
- Monika KatkoMKMonika Katko
- Fruzsina Reka PappFPFruzsina Reka Papp
- Robert CsikiRCRobert Csiki
- Sara CsihaSCSara Csiha
- Annamaria ErdeiAEAnnamaria Erdei
- Miklos BodorMBMiklos Bodor
- Bernadett UjhelyiBernadett Ujhelyi
- Zita SteiberZSZita Steiber
- Ferenc GyoryFGFerenc Gyory
- Endre V. NagyENEndre V. Nagy
Open Access
Abstract
Orbital connective tissue expansion is a hallmark of Graves’ orbitopathy (GO). In moderate-to-severe active GO, glucocorticoids (GC) are the first line of treatment. Here we show that hydrocortisone (HC), prednisolone (P), methylprednisolone (MP), and dexamethasone (DEX) inhibit the hyaluronan (HA) production of orbital (OF) and dermal (DF) fibroblasts. HA production of GO OFs (n = 4), NON-GO OFs (n = 4) and DFs (n = 4) was measured by ELISA. mRNA expression of enzymes of HA metabolism and fibroblast proliferation was examined by RT-PCR and BrdU incorporation, respectively. After 24 h of GC treatment (1µM) HA production decreased by an average of 67.9 ± 3.11% (p < 0.0001) in all cell cultures. HAS2, HAS3 and HYAL1 expression in OFs also decreased (p = 0.009, p = 0.0005 and p = 0.015, respectively). Ten ng/mL PDGF-BB increased HA production and fibroblast proliferation in all cell lines (p < 0.0001); GC treatment remained effective and reduced HA production under PDGF-BB-stimulated conditions (p < 0.0001). MP and DEX reduced (p < 0.001, p = 0.002, respectively) PDGF-BB-induced HAS2 expression in OFs. MP and DEX treatment decreased PDGF-BB stimulated HAS3 expression (p = 0.035 and p = 0.029, respectively). None of the GCs tested reduced the PDGF-BB stimulated proliferation rate. Our results confirm that GCs directly reduce the HA production of OFs, which may contribute to the beneficial effect of GCs in GO.Keywords
Funding Information
- Hungarian National Research, Development and Innovation Office (K 143464)
This publication has 40 references indexed in Scilit:
- Hyaluronan Synthesis Is Inhibited by Adenosine Monophosphate-activated Protein Kinase through the Regulation of HAS2 Activity in Human Aortic Smooth Muscle CellsJournal of Biological Chemistry, 2011
- Platelet-Derived Growth Factor-BB: A Stimulus for Cytokine Production by Orbital Fibroblasts in Graves' OphthalmopathyInvestigative Ophthalmology & Visual Science, 2010
- Dermal Hyaluronan Is Rapidly Reduced by Topical Treatment with GlucocorticoidsJournal of Investigative Dermatology, 2010
- Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BBBiochemical Journal, 2007
- Susceptibility genes in Graves’ ophthalmopathy: searching for a needle in a haystack?Clinical Endocrinology, 2007
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathwayRheumatology, 2003
- Mammalian Hyaluronan SynthasesIUBMB Life, 2002
- Effects of Methylprednisolone Administration on Lymphocyte LECAM‐1, CD44, and LFA‐1 ExpressionAnnals of the New York Academy of Sciences, 1993
- Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. Similar effects of glucocorticoid and thyroid hormones.Journal of Clinical Investigation, 1984